ViiV drug Triumeq for HIV just launched a television campaign. HIV drugs have not used television historically choosing instead targeted print as its main media. The number of people who have HIV is about 1.1 million in the United States. HIV can be successfully treated and newer drugs have turned what was once a deadly […]
First, I am now back writing my weekly column after taking a couple of months off to recharge my batteries. Happy to be back giving my thoughts on issues affecting our DTC community. As I was watching CNN discuss healthcare reform yesterday I was surprised to hear host Chris Cuomo say drug prices were the […]
Specialty Drug Marketers Can Tap into Patient Stories Stories are ingrained in us from the time we are infants. The nighttime ritual of parents and children cozying up with a storybook or two is a genuine and enjoyable encounter, one with an underlying message or lesson that is served in a palatable way. Once we […]
This week many drug CEOs met with President Trump to discuss pricing and innovation. In just two weeks Mr. Trump has sat down with a number of business leaders to push domestic investment in job creation. He pushed the drug makers to build factories here and get control of drug prices. In return Trump promised […]
The arbitrary reviewers at FDA have decided that Otezla and Toujeo have music that is disturbing the peace. They have knocked on the walls of Celgene and Sanofi by issuing letters saying their television ads violate the law. How do they know they broke the law? The beauty of the FDA system is they decide […]
The latest critical DTC story just appeared in Ad Age on 9/12. It deserves comment because it seems off base. In the title it says big pharma is using terror tactics to scare up sales. The crux of the story is how drug companies are shifting to creative approaches using scare tactics in their ads. […]
The drug companies made Hillary’s enemies list earlier this year along with Iran, the Republicans, and the NRA. She now has a plan to ensure drug prices do not rise higher than whatever she thinks is fair. The essence of her plan is to allow government to decide whether a drug price increase is justified. […]
At this year’s CES conference, MC10’s two showcased products were nothing short of groundbreaking. By debuting two different wearables, one aimed to satisfy the medical community while the other targeting the general consumer, the company succeeded in sparking interest. The first product, known as BioStamp Research Connect, is designed to assist researchers with a multitude […]
By Faruk Abdullah of Applied Predictive Technologies Pharmaceutical marketing is changing. With increased industry spend, new marketing channels, a more informed consumer, and a shifting healthcare landscape, it is clear that marketers need to be smarter than ever with their investment decisions. It is also clear that DTC marketing is no longer just about pumping […]
Stop the coughing before it becomes a social media plague. By Peter Friedman of LiveWorld It’s taken a while, but the pharmaceutical industry has slowly realized the value of social media to reach caregivers, health care professionals, and patients to raise awareness and even track adverse events. According to the IMS Institute for Healthcare Informatics, […]
